Pharmarise Holdings Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3802320006
JPY
531.00
-1 (-0.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
May'25
May'24
May'23
May'22
May'21
May'20
May'19
Net Sales
63,508.00
54,466.00
52,030.00
51,608.00
52,324.00
51,030.00
51,728.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
63,508.00
54,466.00
52,030.00
51,608.00
52,324.00
51,030.00
51,728.00
Raw Material Cost
55,305.00
46,574.00
44,531.00
44,191.00
44,994.00
44,298.00
45,078.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
178.00
66.00
55.00
65.00
75.00
74.00
82.00
Selling and Distribution Expenses
7,908.00
4,359.00
3,715.00
3,514.00
3,644.00
3,500.00
3,653.00
Other Expenses
-17.80
-5.40
-4.20
-5.40
-5.30
-6.50
-6.90
Total Expenditure (Excl Depreciation)
63,213.00
50,945.00
48,259.00
47,716.00
48,660.00
47,807.00
48,744.00
Operating Profit (PBDIT) excl Other Income
295
3521
3771
3892
3664
3223
2984
Other Income
61.00
-4.00
1.00
-21.00
85.00
120.00
20.00
Operating Profit (PBDIT)
1,849.00
2,082.00
2,664.00
2,808.00
2,676.00
2,345.00
1,883.00
Interest
178.00
66.00
55.00
65.00
75.00
74.00
82.00
Exceptional Items
-211.00
-703.00
-334.00
-112.00
-56.00
-228.00
-176.00
Gross Profit (PBDT)
8,203.00
7,892.00
7,499.00
7,417.00
7,330.00
6,732.00
6,650.00
Depreciation
1,493.00
1,170.00
1,224.00
1,308.00
1,344.00
1,228.00
1,223.00
Profit Before Tax
8.00
143.00
1,049.00
1,322.00
1,202.00
819.00
400.00
Tax
390.00
485.00
702.00
864.00
782.00
238.00
410.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-368.00
-351.00
333.00
448.00
425.00
577.00
23.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-368.00
-351.00
333.00
448.00
425.00
577.00
23.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-13.00
9.00
14.00
10.00
-6.00
3.00
-33.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-381.00
-342.00
347.00
458.00
419.00
580.00
-10.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,869.00
7,362.00
6,882.00
6,608.00
6,221.00
5,909.00
5,466.00
Earnings per share (EPS)
-32.42
-33.35
26.86
36.22
34.59
46.32
2.12
Diluted Earnings per share
-32.42
-33.35
26.86
36.22
34.59
46.32
2.12
Operating Profit Margin (Excl OI)
0.46%
1.68%
2.77%
2.95%
2.38%
1.95%
1.24%
Gross Profit Margin
2.36%
2.41%
4.37%
5.1%
4.87%
4.01%
3.14%
PAT Margin
-0.58%
-0.64%
0.64%
0.87%
0.81%
1.13%
0.04%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended May 2025 is 16.60% vs 4.68% in May 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended May 2025 is -11.40% vs -198.56% in May 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended May 2025 is -14.29% vs -21.67% in May 2024

stock-summary

Interest

YoY Growth in year ended May 2025 is 169.70% vs 20.00% in May 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended May 2025 has fallen from May 2024

Compare Annual Results Of Pharmarise Holdings Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
63,508.00
132.69
63,375.31
47,761.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
63,508.00
132.69
63,375.31
47,761.93%
Raw Material Cost
55,305.00
3.81
55,301.19
1,451,474.80%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
178.00
0.00
178.00
Selling and Distribution Expenses
7,908.00
158.15
7,749.85
4,900.32%
Other Expenses
-17.80
13.29
-31.09
-233.94%
Total Expenditure (Excl Depreciation)
63,213.00
294.83
62,918.17
21,340.49%
Operating Profit (PBDIT) excl Other Income
295.00
-162.13
457.13
281.95%
Other Income
61.00
-0.16
61.16
38,225.00%
Operating Profit (PBDIT)
1,849.00
-178.93
2,027.93
1,133.37%
Interest
178.00
0.00
178.00
Exceptional Items
-211.00
322.75
-533.75
-165.38%
Gross Profit (PBDT)
8,203.00
128.88
8,074.12
6,264.84%
Depreciation
1,493.00
0.06
1,492.94
2,488,233.33%
Profit Before Tax
8.00
143.76
-135.76
-94.44%
Tax
390.00
30.34
359.66
1,185.43%
Provisions and contingencies
0
0
0.00
Profit After Tax
-368.00
113.43
-481.43
-424.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-368.00
113.43
-481.43
-424.43%
Share in Profit of Associates
0
0
0.00
Minority Interest
-13.00
0.00
-13.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-381.00
113.43
-494.43
-435.89%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,869.00
1,720.15
5,148.85
299.33%
Earnings per share (EPS)
-32.42
8.92
-41.34
-463.45%
Diluted Earnings per share
-32.42
8.92
-41.34
-463.45%
Operating Profit Margin (Excl OI)
0.46%
-134.77%
0.00
135.23%
Gross Profit Margin
2.36%
108.39%
0.00
-106.03%
PAT Margin
-0.58%
85.48%
0.00
-86.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 6,350.80 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is 16.60% vs 4.68% in May 2024

Annual - Consolidate Net Profit
Consolidate Net Profit -38.10 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is -11.40% vs -198.56% in May 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 178.80 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is -14.29% vs -21.67% in May 2024

Annual - Interest
Interest 17.80 Million
in May 2025

Figures in Million
stock-summary

YoY Growth in year ended May 2025 is 169.70% vs 20.00% in May 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.46%
in May 2025

Figures in %
stock-summary

YoY Growth in year ended May 2025 has fallen from May 2024